Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT04838678 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Sympathetic Transduction in Obesity-associated Hypertension (OB-HTN)

Study acronym: OB-HTN
StatusRecruiting
PhaseEarly Phase 1
Started2021-07-18
View on ClinicalTrials.gov ↗
The purpose of this study is to understand how the nervous system communicates to blood vessels to increase blood pressure during stress. The study will also investigate how hypertension and obesity influence the nervous system and vascular function. The study will involve measuring sympathetic nervous system activity and blood flow during common laboratory physiological stress protocols (e.g. hypoxia, exercise), and in response to infusion of drugs that cause vasodilation or vasoconstriction.

Amendment history 2 changes detected by DataLookout

2026-09-04
notable
Primary completion pushed: 2026-08-31 → 2026-12-31
2026-09-04
minor
Completion pushed: 2026-08-31 → 2026-12-31
Trial Details
NCT Number NCT04838678
Lead Sponsor University of Texas Southwestern Medical Center
Conditions Hypertension, Obesity
Enrollment 100 participants
Start Date 2021-07-18
Primary Completion 2026-12-31 (estimated)
Study Completion 2026-12-31 (estimated)
Updated on ClinicalTrials.gov 2026-09-03